OptimizeRx Co. (NASDAQ:OPRX) – B. Riley reduced their Q1 2019 earnings estimates for shares of OptimizeRx in a research note issued on Wednesday, February 27th. B. Riley analyst A. D’silva now anticipates that the company will earn ($0.05) per share for the quarter, down from their prior forecast of $0.01. B. Riley also issued estimates […]